0.45
+0.008(+1.82%)
Currency In USD
| Previous Close | 0.44 |
| Open | 0.45 |
| Day High | 0.45 |
| Day Low | 0.44 |
| 52-Week High | 4.28 |
| 52-Week Low | 0.3 |
| Volume | 823,515 |
| Average Volume | 2.62M |
| Market Cap | 30.4M |
| PE | -0.7 |
| EPS | -0.64 |
| Moving Average 50 Days | 0.44 |
| Moving Average 200 Days | 1.06 |
| Change | 0.01 |
If you invested $1000 in Reviva Pharmaceuticals Holdings, Inc. (RVPH) since IPO date, it would be worth $46.04 as of September 09, 2025 at a share price of $0.447. Whereas If you bought $1000 worth of Reviva Pharmaceuticals Holdings, Inc. (RVPH) shares 5 years ago, it would be worth $41.62 as of September 09, 2025 at a share price of $0.447.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Reviva Pharmaceuticals Holdings, Inc. Announces Pricing of $10 Million Public Offering
GlobeNewswire Inc.
Jun 26, 2025 12:40 PM GMT
CUPERTINO, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
GlobeNewswire Inc.
Jun 25, 2025 8:17 PM GMT
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
GlobeNewswire Inc.
Jun 05, 2025 12:00 PM GMT
CUPERTINO, Calif., June 05, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of